ANGELO HERBU: Open Payments
NPI 1265472096 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,325 in 109 payments from 9 companies in 2025. Trend: 2023 $1,453 · 2024 $1,248 · 2025 $2,325
Food & beverage: $2,325
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $427 |
| Teva Pharmaceuticals USA, Inc. | 33 | $393 |
| Otsuka America Pharmaceutical, Inc. | 11 | $353 |
| ABBVIE INC. | 17 | $343 |
| E.R. Squibb & Sons, L.L.C. | 23 | $328 |
| Neurocrine BioSciences, Inc. | 5 | $217 |
| Alkermes, Inc. | 3 | $167 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, COBENFY, INGREZZA, REXULTI, ABILIFY MAINTENA, LYBALVI.
Industry payments across FL — which companies pay providers there.
